论文部分内容阅读
目的:提高维生素B_1临床使用的安全性。方法:从维生素B_1床使用管理等的相关情况并结合万方数据库收载其过敏反应病例资料进行论述。结果:行业管理部门、医院管理者及相关从业人员不重视维生素B_1使用的安全性,对其临床使用管理仍沿袭长期习惯性使用无监管的管理方式;万方数据库维生素B_1片剂1例和注射剂19例过敏反应病例资料显示:15例过敏性休克其中1例死亡,5例为其他过敏症状。结论:维生素B_1临床长期习惯性使用无监管的管理方式对药品使用者和医疗机构相关从业人员将带来风险和危害。
Objective: To improve the safety of clinical use of vitamin B_1. Methods: From the use of vitamin B_1 bed management and other relevant circumstances, combined with the Wanfang database containing allergic reaction case data to be discussed. Results: The management of the industry, hospital administrators and related employees did not regard the safety of the use of vitamin B_1, and the management of their clinical use still followed the long-term habit of using unsupervised management methods. One case of vitamin B_1 tablet and injection 19 cases of allergic reaction data show: 15 cases of anaphylactic shock, 1 case died, 5 cases of other allergic symptoms. CONCLUSION: Long-term habitual use of vitamin B-1 in clinical management without supervision means risks and harms to drug users and related practitioners in medical institutions.